Publication|Articles|April 18, 2025
- Pharmaceutical Executive: April 2025
- Volume 45
- Issue 3
Pharmaceutical Executive: April 2025 Interactive Digital Edition
View the Pharmaceutical Executive April 2025 issue in an interactive format.
Advertisement
Click
Articles in this issue
about 1 year ago
‘Earning’ Powerabout 1 year ago
Milan Kalawadia: Carving Out New Pathwaysabout 1 year ago
Bringing Biotech Innovation Across Bordersabout 1 year ago
Using AI to Predict Launch Successabout 1 year ago
Improving Your Earned Media Strategy: Tips and Insightsabout 1 year ago
The Future of DTC in Pharmaabout 1 year ago
Maintaining Supply Chain Resiliency, No Matter the Circumstancesabout 1 year ago
Translating ‘Digital-First’ to Commercial Successabout 1 year ago
HEOR: From Proving Product Value to Proving Its Own WorthNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Asembia ASX26: Adjusting Strategies to Adapt to an Uncertain Global Political and Regulatory Market
2
Which Supply Chains are Most Exposed by Disruptions in The Strait of Hormuz?
3
Teva Enters $900 Million Agreement to Acquire Emalex
4
Pharmaceutical Risks in the Strait of Hormuz
5